Results 61 to 70 of about 3,884 (191)

PENINGKATAN KETRAMPILAN MEMBACA INDAH GEGURITAN MELALUI TEKNIK “BASMI KORUPSII” SISWA KELAS VII-A DI SMPN 23 SURABAYA

LEARNING : Jurnal Inovasi Penelitian Pendidikan dan Pembelajaran, 2021
Penelitian ini bertujuan untuk mendekripsikan proses peningkatan ketrampilan membaca indah geguritan siswa kelas VII-A SMP Negeri 23 Surabaya semester genap tahun pelajaran 2020/2021 melalui teknik BASMI KORUPSII dan mendekripsikan peningkatan ketrampilan membaca indah geguritan siswa kelas VII-A SMP Negeri 23 Surabaya semester genap tahun pelajaran ...
openaire   +2 more sources

Efficacy and Safety of Intravenous Secukinumab in Patients With Active Axial Spondyloarthritis: Results From a Randomized, Placebo‐Controlled, Phase 3 Study

Arthritis &Rheumatology, Volume 77, Issue 2, Page 163-170, February 2025.
Objective Our goal was to assess the efficacy and safety of intravenous (IV) secukinumab for the treatment of adults with active axial spondyloarthritis (axSpA) in INVIGORATE‐1. Methods INVIGORATE‐1 (NCT04156620) was a randomized, double‐blind, parallel‐group, phase 3 trial in patients with active axSpA (either radiographic or nonradiographic ...
Atul Deodhar, Jerzy Supronik, Alan Kivitz, Guillermo Valenzuela, Karen Kapur, Susanne Rohrer, Eva Dokoupilová, Hanno B. Richards, Karel Pavelka   +8 more
wiley   +1 more source

Exploring the influence of sagittal imbalance on spinal mobility, function and quality of life in axial spondyloarthritis: a novel comprehensive compensatory mechanism of adaptation

Advances in Rheumatology
Objectives To investigate whether sagittal imbalance, defined by sagittal vertical axis (SVA) using EOS® imaging, is associated with spinal mobility, function, and quality of life in patients with axial spondyloarthritis (axSpA).
Thauana Luiza de Oliveira, Flávio Duarte Silva, Alípio Gomes Ormond Filho, Marcelo Astolfi Caetano Nico, Artur da Rocha Correa Fernandes, Sofia Ramiro, Marcelo de Medeiros Pinheiro   +6 more
doaj   +1 more source

Features of Axial Spondyloarthritis in Two Multicenter Cohorts of Patients with Psoriasis, Uveitis, and Colitis Presenting with Undiagnosed Back Pain

Arthritis &Rheumatology, Volume 77, Issue 1, Page 47-58, January 2025.
Objective We aimed to assess the following: (1) the frequency of axial spondyloarthritis (axSpA) according to extra‐articular presentation and HLA‐B27 status, (2) clinical and imaging features that distinguish axSpA from non‐axSpA, and (3) the impact of magnetic resonance imaging (MRI) on diagnosis and classification of axSpA. Methods The Screening for
Walter P. Maksymowych, Raj Carmona, Ulrich Weber, Sibel Zehra Aydin, James Yeung, Jodie Reis, Ariel Masetto, Sherry Rohekar, Dianne Mosher, Olga Zouzina, Liam Martin, Stephanie O. Keeling, Joel Paschke, Rana Dadashova, Amanda Carapellucci, Stephanie Wichuk, Robert G. Lambert, Jonathan Chan   +17 more
wiley   +1 more source

Relevance of structural damage in the sacroiliac joints for the functional status and spinal mobility in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort

Arthritis Research & Therapy, 2017
Background Functional status and spinal mobility in patients with axial spondyloarthritis (axSpA) are known to be determined both by disease activity and by structural damage in the spine. The impact of structural damage in the sacroiliac joints (SIJ) on
Mikhail Protopopov, Joachim Sieper, Hildrun Haibel, Joachim Listing, Martin Rudwaleit, Denis Poddubnyy   +5 more
doaj   +1 more source

Minat Baca dan Promosi Perpustakaan sebagai Sarana Mendekatkan Masyarakat pada Perpustakaan [PDF]

, 2015
Keberadaan perpustakaan seringkali terabaikan bagi para pencari informasi. Keadaan inidisebabkan karena masyarakat belum mengetahui tentang perpustakaan dan juga minat bacamasyarakat yang masih kurang.
Asdam, B. (Basmi)
core  

The bone bridge significantly affects the decrease in bone mineral density measured with quantitative computed tomography in ankylosing spondylitis.

PLoS ONE, 2021
Introduction and objectiveAnkylosing spondylitis (AS) has characteristics of spinal bone bridge and fusion. Although BMD reduction in AS may be presumed to be due to spinal inflammation, this study was designed to confirm whether immobilization of the ...
So Yun Lee, Ran Song, Hyung In Yang, Sang Wan Chung, Yeon-Ah Lee, Seung-Jae Hong, Seong Jong Yun, Sang-Hoon Lee   +7 more
doaj   +1 more source

Initiation of vedolizumab did not provoke new‐onset spondylarthritis in patients with inflammatory bowel disease: A prospective 24‐week study with imaging assessments

United European Gastroenterology Journal, Volume 12, Issue 7, Page 859-869, September 2024.
There was no association between initiation of vedolizumab and new onset spondylarthritis in patients with IBD, who were prospectively followed up with serial clinical and imaging assessments. Abstract Background A temporal relationship between vedolizumab and new‐onset spondyloarthritis (SpA) has been suggested.
Sherry Rohekar, Tristan Boyd, Robert G. Lambert, Melanie Beaton, Nilesh Chande, Jamie Gregor, Heather Lennox, Keith Mcintosh, Terry Ponich, Adam Rahman, Trimadhu Sharma, Michael Sey, Maria Tauqir, Vipul Jairath   +13 more
wiley   +1 more source

A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis [PDF]

, 2010
The signs and symptoms of ankylosing spondylitis (AS) respond inadequately to nonsteroidal antiinflammatory drugs, corticosteroids, and disease modifying antirheumatic drugs in quite a number of patients.
Ciccia, F., Ferrante, A., Giardina, A., Impastato, R., Miceli, M., Principato, A., Triolo, G.   +6 more
core   +1 more source

Upadacitinib in Active Non‐radiographic Axial Spondyloarthritis: 1‐Year Data From a Double‐Blind, Randomized, Placebo‐Controlled, Phase 3 Trial

ACR Open Rheumatology, Volume 6, Issue 8, Page 470-480, August 2024.
Objective Upadacitinib improved the signs and symptoms of non‐radiographic axial spondyloarthritis (nr‐axSpA) versus placebo over 14 weeks in the primary analysis of the SELECT‐AXIS 2 nr‐axSpA study. Here, we evaluated the efficacy and safety of upadacitinib through 1 year in patients with nr‐axSpA in SELECT‐AXIS 2.
Filip Van den Bosch, Atul Deodhar, Denis Poddubnyy, Walter P. Maksymowych, Désirée van der Heijde, Tae‐Hwan Kim, Mitsumasa Kishimoto, Xenofon Baraliakos, Yihan Li, Kristin D'Silva, Peter Wung, In‐Ho Song   +11 more
wiley   +1 more source